Skip to main content
. Author manuscript; available in PMC: 2012 Feb 18.
Published in final edited form as: Oncogene. 2011 Mar 21;30(33):3563–3569. doi: 10.1038/onc.2011.76

Figure 4. Expression levels of HEXIM1 in breast tissue from case control study of breast cancer patients treated with tamoxifen.

Figure 4

Sections from tumor specimens obtained from matched “control” and “case” patients were stained for endogenous HEXIM1 as described in the "Materials and Methods" section. “Cases” were defined as having recurred earlier than their matched controls. Shown is the graph of logit (log(p/(1-p)) proportion of patient (p) with breast cancer recurrence after tamoxifen within each of five approximately equal size groups based on HEXIM1 expression.